FDA Clearance Tracker · K183123
microTargeting Guideline 4000 5.0 System
Last checked: Nov 19, 2026Latest source record: Dec 20, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Dec 20, 2018
Substantially Equivalent
Time to decision
37 days
Received Nov 13, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K183123
- Device name
- microTargeting Guideline 4000 5.0 System
- Applicant
- FHC, Inc.
- Applicant location
- Bowdoin, ME
- Received
- Nov 13, 2018
- Decided
- Dec 20, 2018
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Electrode, Depth (GZL)
- Device class
- Class II
- Regulation
- 21 CFR 882.1330
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GZL. The earliest in FDA's data is K802152, decided Nov 19, 1980.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K183123
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for FHC, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K231141 · Decided Sep 8, 2023 · 140 days after receipt
Device type: Surgical Planning Software For Neurological Stereotaxic Instruments (QRI) · Neurology & Neurosurgery
K200169 · Decided May 14, 2020 · 112 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.